Literature DB >> 33442865

Influence of relevant cystic fibrosis bacteria on Scedosporium apiospermum and Scedosporium boydii growth and viability.

Andressa de Jesus Marques1,2,3, Rodrigo Rollin-Pinheiro2, Mariana Ingrid Dutra da Silva Xisto2, André Luis Souza Dos Santos2, Eliana Barreto-Bergter2, Livia Cristina Liporagi-Lopes4,5,6.   

Abstract

Cystic fibrosis (CF) causes a variety of symptoms in different organs, but the majority of the morbidity and mortality of CF is related with pulmonary conditions. Primary infections are usually bacterial, and when treated with antibiotics, yeast infections appear or become more evident. Studies show that different microorganisms can co-inhabit the same environment and the interactions could be synergistic or antagonistic. Using techniques including viable and non-viable cell-to-cell interactions, mixed culture in liquid, and solid media sharing or not the supernatant, this study has evaluated interactions between the fungal species Scedosporium apiospermum and Scedosporium boydii with the bacterial species Staphylococcus aureus, Pseudomonas aeruginosa, and Burkholderia cepacia. Cell-to-cell interactions in liquid medium showed that P. aeruginosa and B. cepacia were able to reduce fungal viability but only in the presence of alive bacteria. Interactions without cell contact using a semi-permeable membrane showed that all bacteria were able to inhibit both fungal growths/viabilities. Cell-free supernatants from bacterial growth reduced fungal viability in planktonic fungal cells as well as in some conditions for preformed fungal biomass. According to the chemical analysis of the bacterial supernatants, the predominant component is protein. In this work, we verified that bacterial cells and their metabolites, present in the supernatants, can play anti-S. apiospermum and anti-S. boydii roles on fungal growth and viability.

Entities:  

Keywords:  Bacteria; Cystic fibrosis; Growth; Scedosporium; Viability

Mesh:

Year:  2021        PMID: 33442865      PMCID: PMC7966697          DOI: 10.1007/s42770-020-00415-w

Source DB:  PubMed          Journal:  Braz J Microbiol        ISSN: 1517-8382            Impact factor:   2.476


  45 in total

1.  The Pseudomonas aeruginosa quinolone signal (PQS) has an iron-chelating activity.

Authors:  Florian Bredenbruch; Robert Geffers; Manfred Nimtz; Jan Buer; Susanne Häussler
Journal:  Environ Microbiol       Date:  2006-08       Impact factor: 5.491

2.  Isolation and characterization of antifungal substances from Burkholderia sp. culture broth.

Authors:  Sopheareth Mao; Seung-Je Lee; Hoon Hwangbo; Yong-Woong Kim; Keun-Hyung Park; Gyu-Suk Cha; Ro-Dong Park; Kil-Yong Kim
Journal:  Curr Microbiol       Date:  2006-10-19       Impact factor: 2.188

3.  In vitro activities of four novel triazoles against Scedosporium spp.

Authors:  A J Carrillo; J Guarro
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

4.  Advances in understanding and managing Scedosporium respiratory infections in patients with cystic fibrosis.

Authors:  Jean-Philippe Bouchara; Yohann Le Govic; Samar Kabbara; Bernard Cimon; Rachid Zouhair; Monzer Hamze; Nicolas Papon; Gilles Nevez
Journal:  Expert Rev Respir Med       Date:  2019-12-23       Impact factor: 3.772

5.  Comparative in-vitro activity of voriconazole (UK-109,496) and six other antifungal agents against clinical isolates of Scedosporium prolificans and Scedosporium apiospermum.

Authors:  M Cuenca-Estrella; B Ruiz-Díez; J V Martínez-Suárez; A Monzón; J L Rodríguez-Tudela
Journal:  J Antimicrob Chemother       Date:  1999-01       Impact factor: 5.790

6.  Species-specific antifungal susceptibility patterns of Scedosporium and Pseudallescheria species.

Authors:  Michaela Lackner; G Sybren de Hoog; Paul E Verweij; Mohammad J Najafzadeh; Ilse Curfs-Breuker; Corné H Klaassen; Jacques F Meis
Journal:  Antimicrob Agents Chemother       Date:  2012-01-30       Impact factor: 5.191

Review 7.  Aspergillus infections in cystic fibrosis.

Authors:  Jill King; Shan F Brunel; Adilia Warris
Journal:  J Infect       Date:  2016-05-11       Impact factor: 6.072

8.  Cis-2-dodecenoic Acid Mediates Its Synergistic Effect with Triazoles by Interfering with Efflux Pumps in Fluconazole-resistant Candida albicans.

Authors:  Dong Liang Yang; Yan Ling Hu; Zi Xin Yin; Gui Sheng Zeng; Dan Li; Yu Qian Zhang; Zhen Hua Xu; Xiao Ming Guan; Li Xing Weng; Lian Hui Wang
Journal:  Biomed Environ Sci       Date:  2019-03       Impact factor: 3.118

9.  Experimental models of disseminated scedosporiosis with cerebral involvement.

Authors:  Bénédicte Lelièvre; Pierre Legras; Charlotte Godon; Florence Franconi; Jean-Paul Saint-André; Jean-Philippe Bouchara; Bertrand Diquet
Journal:  J Pharmacol Exp Ther       Date:  2013-02-20       Impact factor: 4.030

Review 10.  The cystic fibrosis airway microbiome.

Authors:  Harvey R Rabin; Michael G Surette
Journal:  Curr Opin Pulm Med       Date:  2012-11       Impact factor: 3.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.